Multidrug resistance (MDR) of *Acinetobacter baumannii* increasingly jeopardizes the health care setting leading to substantial mortality and morbidity globally. During the past decade, entirely resistant *A. baumannii* strains presented a real challenge to clinicians and posed difficulties in therapy ([@CIT0001], [@CIT0002]). MDR of *A. baumannii--*associated infections, with adverse clinical outcomes involving the respiratory tract, blood, soft tissues, urinary tract, and central nervous system, significantly increases the outlay of the infirmary. Being Gram-negative coccobacilli and an obligate aerobe, *A. baumannii* causes both community- and hospital-acquired infection outbreaks in intensive care units especially in countries with tropical climates ([@CIT0003], [@CIT0004]). Of particular concern, we sought to reveal the status of antimicrobial resistance in *A. baumannii* bacteremia isolates, the trends and relative frequency of multidrug resistance pattern and also the underlying clinical condition among patients with *A. baumannii* bacteremia at Riyadh Military hospital, Saudi Arabia, from January 2005 to December 2010.

Our retrospective study was conducted at Riyadh military Hospital, Riyadh, Saudi Arabia, which is a tertiary health care center with a capacity of 1,200 beds. Identification of the microorganism was done using the microbiology laboratory protocol, and those non-repetitive clinical cultures that showed positive for *A. baumannii* during a 5-year period from January 2005 to December 2010 were included in the study. Blood cultures were performed using the BACTEC 9,240 system (Becton--Dickinson Sparks, MD, USA). A total of 380 *A. baumannii* blood isolates were identified in blood cultures between January 2005 and December 2010 and confirmed by API 20 NE (bioMerieux Inc., France). Isolation and identification was followed by antibiotic typing of these 380 blood isolates by MicroScan WalkAway (Dade Behring Inc., West Sacramento, CA, USA) according to manufacturer specifications. Antibiotic patterns were determined in accordance with CLSI guidelines. The antimicrobial agents used in this study were amikacin (AK), ampicillin--sulbactam (AM--S), cetazidime (CFZ), ceftriaxone (CFN), ciprofloxacin (CIP), gentamicin (GEN), meropenem (MERO), netilmicin (NET), piperacillin/tazobactam (PT), trimethoprim/sulfamethoxazole (TM-SXT), and tetracycline (TET). Intermediately, susceptible strains were considered to be resistant. All laboratory testing was performed according to manufacturer specifications for that instrument in accordance with practices recommended by CLSI.

Multidrug resistant *A. baumannii* (MDR-AB) is classically recognized and defined if it is resistant to three or more classes of antibiotics. Statistical analysis was done using a *t-*test, and *P*\<0.05 was considered significant.

[Table 1](#T0001){ref-type="table"} depicts the resistance profiles of all the cases and consequently the fluctuations in the susceptibility patterns during the study years. [Table 2](#T0002){ref-type="table"} describes the frequency of *A. baumannii* isolation from blood during the year 2005--2010 and also the preponderance of MDR-AB during these retrospective years. Resistance to most potent drugs for *A. baumannii--*associated infections, namely AK, CFN, and MERO firmly increased to 50, 71, and 55% during the year 2009 from 21, 42, and 12%, respectively during year the 2005. Resistance to AM-S fluctuated in these years maximizing in the year 2009 to 60%, and similarly the resistance rates to CIP (60%) and GEN (55%) attained peak values during the year 2009. It was noted that there has been a steady increase in the resistance rates of *A. baumannii* isolates, thereby increasing the relative frequency of MDR-AB strains. The number of *A. baumannii* isolated from blood culture increased considerably from 49 to 110 in the period 2005--2010. Moreover, MDR-AB-associated infections endangered the hospital settings by their significant predominance in ICU as 76 and 75% in 2006 and 2008, respectively. A substantial increase in MDR-AB strains is horrendous since MDR-AB were significantly isolated from ICU patients ([@CIT0005]). Apart from being MDR, the steady increase in resistance rates of these bacteriemic isolates to MERO is certainly noteworthy as it reflects the probability of a nosocomial outbreak of carbapenam-resistant clones of *A. baumannii*. The number of cases of MDR-AB isolated from non-ICU patients in the years 2005 and 2009 were 12 \[63%\] and 9 \[75%\], respectively, which was higher than that isolated from ICU patients in the same years (7 \[37%\]) and 3 \[25%\], respectively). Moreover, the MDR rate was 63% in 2005 whereas 72% in 2009, thus prevailing antimicrobial resistance pattern among the ICU patients is alarming in the hospital care settings.

###### 

Prevalence and resistance trends of *Acinetobacter baumannii* bacteremia isolates at Riyadh military hospital, 2005--2010

               Resistance prevalence (%)                                           
  ------ ----- --------------------------- ---- ---- ---- ---- ---- ---- ---- ---- ----
  2005   49    29                          35   41   51   29   31   12   15   39   29
  2006   48    35                          30   48   52   35   44   35   22   62   37
  2007   85    37                          22   46   57   42   44   35   21   51   42
  2008   106   50                          51   53   59   49   53   47   36   61   46
  2009   99    50                          60   58   71   60   55   55   42   78   47
  2010   110   44                          42   54   60   47   42   51   32   70   44

###### 

Characteristic of patients infected with MDR *Acinetobacter baumannii* bacteremia

  Characteristic        2005     2006      2007      2008      2009      2010
  --------------------- -------- --------- --------- --------- --------- ---------
  Mean age (years)      37       44        49        51        52        50
  Male                  28       28        44        62        46        58
  Female                21       20        42        46        53        52
  ICU patients          16       24        25        37        41        23
  Non-ICU patients      33       24        61        71        58        87
  No. of isolated MDR   11       13        29        48        53        52
  MDR in ICU (%)        7 (63)   10 (76)   19 (66)   36 (75)   38 (72)   18 (35)

Our retrospective study suggests that there was a substantial increase in antimicrobial resistance and a relative increase in frequency of the MDR predominating in the blood culture isolates of *A. baumannii*. An optimal treatment for *A. baumannii* infections has not been established, especially for MDR-AB. Decisions on treatment should be made on a case-by-case basis by a health care provider. Extensively resistant *A. baumannii* strains remain generally susceptible to polymyxins (colistin and polymyxin B). Therefore, valid infection control practices and judicious antibiotic strategies are necessary to contain the outbreaks of MDR-AB in nosocomial settings, and clinical alternatives for therapy is mandatory for improved management of infections due to MDR-AB.
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